#1 Clinical Trials Search in Europe

Gentamicin

Gentamicin, a powerful antibiotic, is being studied in various clinical trials to explore its potential in treating different medical conditions. These trials aim to evaluate new applications, dosing regimens, and administration methods for gentamicin to improve patient outcomes and reduce side effects. The research spans diverse areas, including vestibular disorders, skin conditions, catheter-related infections, and more.

Table of Contents

What is Gentamicin?

Gentamicin is an antibiotic medication that belongs to a class of drugs called aminoglycosides. It is primarily used to treat various bacterial infections. Gentamicin is also known by other names such as Gentamicin Sulfate, Gentamycin, and GENTAMICIN INJECTION[1]. This medication works by killing or stopping the growth of bacteria that cause infections.

Uses of Gentamicin

Gentamicin is used to treat a wide range of conditions and infections, including:

  • Catheter-related infections: Gentamicin can be used to treat infections associated with long-term central venous catheters (tubes inserted into large veins for medical treatment)[2].
  • Severe acute malnutrition in HIV-infected or HIV-exposed children: Gentamicin, in combination with other antibiotics, is being studied for its effectiveness in treating infections in malnourished children with HIV[1].
  • Epidermolysis Bullosa (EB): This is a rare genetic skin condition that causes fragile, blistering skin. Gentamicin is being researched for its potential to treat certain types of EB by helping to produce a protein called type VII collagen, which is important for skin strength[3].
  • Catheter-Associated Urinary Tract Infections (CAUTI): Gentamicin is being studied as a potential preventive treatment for urinary tract infections in patients with urinary catheters[4].
  • Vestibular schwannoma: This is a type of non-cancerous tumor that grows on the nerve connecting the ear to the brain. Gentamicin is being investigated as a pre-treatment before surgery to reduce post-operative vertigo (a spinning sensation) and other balance-related symptoms[5].

Administration Methods

Gentamicin can be administered in several ways, depending on the condition being treated:

  • Intravenous (IV) injection: The medication is injected directly into a vein. This method is often used for severe infections[3].
  • Topical application: Gentamicin can be applied directly to the skin in the form of an ointment or cream. This method is being studied for certain skin conditions like Epidermolysis Bullosa[6].
  • Intratympanic injection: In this method, gentamicin is injected into the middle ear. This is being researched for treating balance disorders related to inner ear problems[5].
  • Bladder instillation: Gentamicin solution is inserted directly into the bladder through a catheter. This method is being studied to prevent urinary tract infections in catheterized patients[4].
  • Spray application: In some surgical procedures, gentamicin spray is being studied for its potential to prevent infections. For example, it’s being researched for use during hernia repair surgeries[7].

Potential Side Effects

Like all medications, gentamicin can cause side effects. Some of the potential side effects that researchers are monitoring in clinical trials include:

  • Ototoxicity: This refers to damage to the inner ear, which can affect hearing and balance[3].
  • Nephrotoxicity: This is damage to the kidneys, which can affect kidney function[3].
  • Changes in hearing levels: Some studies are monitoring patients’ hearing before and after gentamicin treatment[5].

It’s important to note that these side effects are being closely monitored in clinical trials, and the benefits of treatment are weighed against potential risks.

Ongoing Research

Gentamicin is the subject of ongoing research to explore its potential in treating various conditions:

  • Nonsense mutation suppression: Researchers are studying whether gentamicin can help “read through” certain genetic mutations in conditions like Epidermolysis Bullosa, potentially restoring protein function[6].
  • Biofilm prevention: Studies are investigating gentamicin’s ability to prevent or treat biofilms (communities of bacteria that stick to surfaces) in catheter-related infections[2].
  • Pre-surgical treatment: Gentamicin is being studied as a pre-treatment before certain surgeries to potentially improve post-operative outcomes, particularly in balance-related disorders[5].
  • Infection prevention in surgical procedures: Research is being conducted on the use of gentamicin spray during surgeries to prevent post-operative infections[7].

These ongoing studies aim to expand our understanding of gentamicin’s potential uses and to develop new treatment strategies for various medical conditions.

Condition Administration Method Key Outcomes Measured
Vestibular Schwannoma Intratympanic injection Postural control, vestibular compensation, quality of life
Recessive Dystrophic Epidermolysis Bullosa (RDEB) Intravenous, topical, intradermal Type VII collagen expression, anchoring fibril formation, wound healing
Catheter-Associated Urinary Tract Infection (CAUTI) Bladder instillation Infection rates, microbial cure
Abdominal Hernia Surgery Spray on surgical mesh Surgical site infection rates
Chorioamnionitis Intravenous Fever resolution, endometritis prevention, neonatal outcomes

FAQ

  • What conditions are being studied using gentamicin in clinical trials? Clinical trials are exploring gentamicin's use in various conditions, including vestibular schwannoma, recessive dystrophic epidermolysis bullosa (RDEB), catheter-related infections, abdominal hernia surgeries, and chorioamnionitis.
  • How is gentamicin being administered in these trials? Gentamicin is being administered through various methods, including intratympanic injections, intravenous infusions, topical applications, intradermal injections, and as a spray during surgeries. Some trials are also exploring novel delivery methods like microneedle rollers.
  • What are the potential benefits of using gentamicin in these trials? Potential benefits include improved vestibular compensation after schwannoma surgery, restoration of type VII collagen in RDEB patients, reduced catheter-related infections, decreased surgical site infections in hernia repairs, and effective treatment of chorioamnionitis.
  • Are there any risks associated with gentamicin use in these trials? The main risks associated with gentamicin use include potential ototoxicity (hearing damage) and nephrotoxicity (kidney damage). These side effects are being closely monitored in the trials, especially when using higher doses or new administration methods.
  • How long do these clinical trials typically last? The duration of these trials varies depending on the condition being studied and the specific research objectives. Some trials follow patients for a few weeks, while others monitor outcomes for up to 6 months or longer to assess long-term effects and safety.

Ongoing Clinical Trials on Gentamicin

  • Study on Gentamicin and Azithromycin for Treating Lymph Node Infection in Cat Scratch Disease Patients

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Gentamicin: An antibiotic medication used to treat various bacterial infections. It belongs to the aminoglycoside class of antibiotics.
  • Vestibular Schwannoma: A benign tumor that develops on the nerve connecting the ear to the brain, which can affect balance and hearing.
  • Recessive Dystrophic Epidermolysis Bullosa (RDEB): A rare genetic skin disorder characterized by extremely fragile skin that blisters and tears easily.
  • Catheter-Associated Urinary Tract Infection (CAUTI): An infection that occurs in people who have a tube (catheter) in their bladder to drain urine.
  • Intratympanic: Referring to administration of medication directly into the middle ear.
  • Ototoxicity: Damage to the ear (particularly to the cochlea or auditory nerve) caused by exposure to certain medications or chemicals, potentially resulting in hearing loss.
  • Nephrotoxicity: Damage to the kidneys caused by exposure to certain medications or chemicals.
  • Anchoring Fibrils: Structures in the skin that help attach the epidermis (outer layer) to the dermis (inner layer), providing strength and stability.
  • Chorioamnionitis: An inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection during pregnancy.
  • Biofilm: A thin, slimy film of bacteria that adheres to a surface, often making infections more difficult to treat.

References

  1. https://clinicaltrials.gov/study/NCT05051163
  2. https://clinicaltrials.gov/study/NCT04789928
  3. https://clinicaltrials.gov/study/NCT03392909
  4. https://clinicaltrials.gov/study/NCT06332040
  5. https://clinicaltrials.gov/study/NCT02379754
  6. https://clinicaltrials.gov/study/NCT04644627
  7. https://clinicaltrials.gov/study/NCT04164524